Innovation and Discovery Highlights

The Centers for Disease Control and Prevention (CDC) has awarded $4.2 million over the next five years to fund the Injury Prevention Research Center at Emory (IPRCE), a center designed to reduce the top causes of injury and injury death in Georgia and the Southeast through research, education and outreach. IPRCE is one of nine centers in the U.S. being funded by the CDC’s National Center for Injury Prevention and Control under the Injury Control Research Center program.

Dr. Nick Sterling (second-year resident in the Emory Emergency Medicine) and Dr. Justin Schrager (EM Attending) are collaboration on multiple research projects using machine learning and natural language processing of free-form text in electronic medical records data. The team recently published a study, "Prediction of emergency department patient disposition based on natural language processing of triage notes," in the International Journal of Machine Learning, demonstrating the use of natural language processing on nursing triage notes to predict patient hospital disposition at the time of initial emergency department triage.

We are looking for color vision deficient Emergency Medicine providers to test the feasibility of wearing EnChroma glasses, glasses that are designed to improve color vision for color vision deficient people. The tests will evaluate any subjective effect that they have on patient care. This study has been approved by the Emory IRB (Grady review is pending). Only open to Emory providers.

The Injury Prevention Research Center at Emory (IPRCE) and the Medical College of Wisconsin were recently awarded a study to develop and pilot test methods for pedestrian motor-vehicle crash investigations (Jonathan Rupp, PI).  Funded by the National Highway Traffic Safety Administration as part of it's Crash Injury Research and Engineering Network (CIREN), the team’s work will provide the foundation for a future, national study of the vehicle, behavioral, and environmental factors influencing the occurrence of pedestrian motor-vehicle crashes and pedestrian injury in such crashes. 

The Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial was an NIH funded clinical trial that started in 2011. GMH and EUH were clinical participating sites as apart of the Neurological Emergency Treatment Trials (NETT) network. The NETT Hub at Emory was awarded to David Wright, MD and SHINE was overseen by Vishal Patel, MD. Hyperglycemia is common in acute stroke patients. The SHINE trial compared intensive early management of glucose (80-130 mg/dL) to standard care.